Stockscreener 앱 받기
21.04
0.66%
-0.3277
전일 마감가:
$21.37
열려 있는:
$21.6
하루 거래량:
234.90K
Relative Volume:
0.05
시가총액:
$5.01B
수익:
$330.24M
순이익/손실:
$34.79M
주가수익비율:
-105.21
EPS:
-0.2
순현금흐름:
$66.12M
1주 성능:
+5.10%
1개월 성능:
+35.92%
6개월 성능:
+121.15%
1년 성능:
+438.83%
1일 변동 폭
$21.01
$21.70
1주일 범위
$18.90
$21.70
52주 변동 폭
$3.60
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
명칭
Adma Biologics Inc
전화
(201) 478-5552
주소
C/O ADMA BIOLOGICS, INC., RAMSEY
ADMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| ADMA | 21.04 | 5.01B | 330.24M | 34.79M | 66.12M | -0.20 |
| VRTX | 445.50 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 737.53 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 585.04 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.28 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.21 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-19 | 재개 | Raymond James | Strong Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 개시 | Jefferies | Buy |
| 2019-04-15 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-07 | 재개 | H.C. Wainwright | Buy |
| 2017-12-11 | 재확인 | Maxim Group | Buy |
| 2017-11-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | 업그레이드 | Maxim Group | Hold → Buy |
| 2016-08-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2016-07-25 | 재확인 | Maxim Group | Buy |
| 2015-05-13 | 재확인 | Maxim Group | Buy |
| 2014-12-08 | 개시 | Oppenheimer | Outperform |
| 2014-12-01 | 재확인 | Maxim Group | Buy |
모두보기
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
ADMA Biologics drops as auditor resigns - MSN
New Millennium Group LLC Acquires New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
First Turn Management LLC Acquires New Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire
Wall Street Analysts See a 31.3% Upside in Adma Biologics (ADMA): Can the Stock Really Move This High? - Yahoo Finance
Oppenheimer & Co. Inc. Has $1.90 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
GSA Capital Partners LLP Sells 109,045 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - Zacks Investment Research
Statutory Profit Doesn't Reflect How Good ADMA Biologics' (NASDAQ:ADMA) Earnings Are - Yahoo Finance
Entropy Technologies LP Purchases Shares of 37,850 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
State of New Jersey Common Pension Fund D Has $2.27 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Janney Montgomery Scott LLC Takes Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
29,143 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Acquired by Aigen Investment Management LP - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Stake Raised by Amalgamated Bank - MarketBeat
Principal Financial Group Inc. Has $23.87 Million Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Los Angeles Capital Management LLC Acquires 67,740 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
ADMA Biologics Inc (ADMA) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Mesirow Financial Investment Management Inc. Sells 30,105 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Stock Traders Buy Large Volume of ADMA Biologics Call Options (NASDAQ:ADMA) - MarketBeat
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance
Lisanti Capital Growth LLC Takes $4.70 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
HC Wainwright Predicts Increased Earnings for ADMA Biologics - MarketBeat
HC Wainwright Issues Positive Forecast for ADMA Biologics (NASDAQ:ADMA) Stock Price - MarketBeat
Earnings Beat: Here's What ADMA Biologics, Inc. (NASDAQ:ADMA) Analysts Are Forecasting For Next Year - Yahoo Finance
ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2024 Earnings Call Transcript - Insider Monkey
Kirby McInerney LLP Reminds ADMA Biologics, Inc. (ADMA) Investors of Shareholder Investigation - WICZ
Robeco Institutional Asset Management B.V. Purchases 68,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
New York State Teachers Retirement System Purchases New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Earnings call: ADMA Biologics reports robust growth, raises guidance - Investing.com India
ADMA Biologics stock soars to all-time high of $21.25 By Investing.com - Investing.com South Africa
ADMA Biologics (NASDAQ:ADMA) Stock Price Expected to Rise, Raymond James Analyst Says - MarketBeat
ADMA Biologics (NASDAQ:ADMA) Reaches New 52-Week HighWhat's Next? - MarketBeat
ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
ADMA Biologics stock soars to all-time high of $21.25 - Investing.com
ADMA INVESTOR NEWS: ADMA Biologics Investors with Losses - GlobeNewswire
Adma Biologics: Q3 Earnings Snapshot - CTPost
ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Reco - GuruFocus.com
ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Record Revenue and Net Income Surge - Yahoo Finance
ADMA Biologics, Inc. Revises Earnings Guidance for the Fiscal Year 2024-2025 - Marketscreener.com
ADMA Biologics Reports Robust Q3 2024 Growth - TipRanks
ADMA Biologics Inc earnings beat by $0.02, revenue topped estimates - Investing.com
ADMA Biologics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance UK
ADMA Biologics Inc Reports Q3 2024 Revenue of $119.8 Million, Su - GuruFocus.com
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Did ADMA Biologics (ADMA) Commit Securities Fraud Resulting in 20% Stock Drop? Contact BFA Law about its Ongoing Investigation - AccessWire
3 High Growth Tech Stocks Leading The US Market - Yahoo Finance
ADMA STOCK ALERT: Why is ADMA Biologics Under Investigation for Securities Fraud? Contact BFA Law if You Lost Money on Your Investment (Nasdaq:ADMA) - AccessWire
ADMA Biologics Inc (ADMA) Q3 2024: Everything You Need To Know A - GuruFocus.com
Adma Biologics Inc (ADMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
0.16%
자본화:
|
볼륨(24시간):